[18F]fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: Impact of verification bias

Michael S. Lauer, Sudish C. Murthy, Eugene H. Blackstone, Ikenna Okereke, Thomas W. Rice

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Background: Verification bias occurs when test findings influence the decision to perform a gold standard test. It adversely influences diagnostic test accuracy by inflating sensitivity and deflating specificity.Westudied the impact of verification bias on the estimated accuracy of a test commonly used in suspected lung cancer. Methods: We studied 534 consecutive patients referred for [18F]fluorodeoxyglucose uptake by positron emission tomography (PET). Primary outcomes were tissue diagnoses of cancer and of mediastinal lymph node metastases. A secondary outcome was 3-year mortality. We accounted for verification bias using 2 validated methods. Results: The gold standard test, namely tissue acquisition, was performed in 419 patients (78%); mediastinal lymph node sampling occurred in 301 (56%). While the 410 patients with PET-diagnosed stage I cancer or higher were more likely than patients with negative PET scan findings to undergo tissue diagnosis testing (92% vs 34%) (P

Original languageEnglish (US)
Pages (from-to)161-165
Number of pages5
JournalArchives of Internal Medicine
Volume167
Issue number2
DOIs
StatePublished - Jan 22 2007
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Internal Medicine

Cite this